David P. Southwell, Director at PTC THERAPEUTICS, INC. (PTCT), sold 5,142 shares at $50.05 ($257K) on 2023-03-31, disclosed to the SEC on 2023-04-04.
Scheduled sale ($257k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $50.05 | 2,571 | $129K | 50.0% |
| 2 | $50.05 | 2,571 | $129K | 50.0% |
| Total | $50.05 avg | 5,142 | $257K | 100% |
| Filing → |
| PTCT | SELL | 2023-04-19 | $1.2M | — | Filing → |
| PTCT | SELL | 2023-03-29 | $897K | — | Filing → |
| TCRX | BUY | 2022-05-20 | $90K | — | Filing → |